Implications and Application of Probiotics in the NICU

Probiotics use in neonates continues to be a topic of interest. While an increasing number of neonatal intensive care units (NICUs) in the US are beginning to use probiotics, many NICUs still don't. Barriers to the use of probiotics include safety implementation concerns, standardization of formulation, dosage, and duration. Further research must be done to address the benefits and barriers. This panel of experts discusses the historical background, benefits, current clinical evidence, and barriers to the use of probiotics in neonates.

CPE Level: Level 3 (advanced knowledge/expertise)
CPEU: 1.5

Performance Indicators

• 8.2.3 Analyzes new information and how it impacts medical nutrition therapy.
• 10.3.6 Develops nutrition prescriptions to communicate clients'/patients' customized diet and nutrition needs.
• 10.4.4 Considers client/patient factors, nutritional impacts, indications, side effects, contraindications, benefits, risks, alternatives and foundational sciences when prescribing, recommending or administering nutrition-related drug therapy.

Learning Objectives

• Describe the role of probiotics in the NICU
• Assess the scientific evidence used to support probiotics in the NICU
• Detail appropriate application of probiotics to clinical practice in neonates

Moderator

• Andie Lee Gonzalez, PhD, MPH, RDN, LD, FAND

Speakers

• Arpitha Chiruvolu, MD, FAAP
• Heather S. Hendrikson, RDN, CSP, LD
• Karyn Wulf, MD, MPH